| Cancer Research and Treatments | Lifetime | 46 | CN 3 | 99.50 |
| Cancer-related molecular mechanisms research | Lifetime | 86 | CN 30 | 99.52 |
| RNA modifications and cancer | Lifetime | 174 | CN 13 | 99.50 |
| Cancer-related Molecular Pathways | Lifetime | 82 | CN 2 | 99.58 |
| Cell death mechanisms and regulation | Lifetime | 64 | CN 5 | 99.39 |
| MicroRNA in disease regulation | Lifetime | 229 | CN 79 | 99.07 |
| Ferroptosis and cancer prognosis | Lifetime | 97 | CN 40 | 98.47 |
| Cancer Mechanisms and Therapy | Lifetime | 91 | CN 8 | 98.86 |
| Circular RNAs in diseases | Lifetime | 171 | CN 91 | 98.65 |
| Ubiquitin and proteasome pathways | Lifetime | 226 | CN 14 | 98.84 |
| Cancer-related gene regulation | Lifetime | 256 | CN 25 | 98.45 |
| Epigenetics and DNA Methylation | Lifetime | 585 | CN 39 | 98.60 |
| Molecular Biology Techniques and Applications | Lifetime | 225 | CN 9 | 97.99 |
| Cancer Cells and Metastasis | Lifetime | 469 | CN 23 | 97.99 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 865 | CN 49 | 97.96 |
| Autophagy in Disease and Therapy | Lifetime | 330 | CN 45 | 97.71 |
| Cancer, Lipids, and Metabolism | Lifetime | 981 | CN 42 | 96.64 |
| Histone Deacetylase Inhibitors Research | Lifetime | 732 | CN 73 | 94.10 |
| NF-κB Signaling Pathways | Lifetime | 619 | CN 40 | 94.92 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 856 | CN 42 | 94.06 |
| Melanoma and MAPK Pathways | Lifetime | 966 | CN 37 | 91.51 |
| Clusterin in disease pathology | Lifetime | 226 | CN 16 | 78.28 |
| Epigenetics and DNA Methylation | 2021-2025 | 159 | CN 69 | 96.77 |
| RNA modifications and cancer | 2021-2025 | 455 | CN 302 | 96.19 |
| Autophagy in Disease and Therapy | 2021-2025 | 178 | CN 92 | 93.81 |
| RNA Research and Splicing | 2021-2025 | 402 | CN 115 | 92.36 |
| Cancer-related gene regulation | 2021-2025 | 187 | CN 124 | 91.55 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 142 | CN 34 | 92.32 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 442 | CN 191 | 91.20 |
| Ferroptosis and cancer prognosis | 2021-2025 | 701 | CN 597 | 91.82 |
| Protein Degradation and Inhibitors | 2021-2025 | 476 | CN 83 | 91.01 |
| Cancer-related Molecular Pathways | 2021-2025 | 289 | CN 49 | 87.31 |
| Cell death mechanisms and regulation | 2021-2025 | 86 | CN 18 | 85.62 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 335 | CN 81 | 84.11 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 909 | CN 203 | 60.57 |
| Biological and pharmacological studies of plants | 2021-2025 | 363 | CN 296 | 59.32 |
| Calcium signaling and nucleotide metabolism | 2021-2025 | 537 | CN 100 | 49.69 |
